Mutation analysis of the apoptotic "death-receptors" and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines

被引:51
作者
Dechant, MJ
Fellenberg, J
Scheuerpflug, CG
Ewerbeck, V
Debatin, KM
机构
[1] Univ Heidelberg, Orthopad Klin, Dept Orthopaed Res, D-69118 Heidelberg, Germany
[2] Univ Ulm, Childrens Hosp, Ulm, Germany
关键词
cancer; apoptosis; osteosarcoma; mutation;
D O I
10.1002/ijc.20008
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Apoptosis is a key mechanism of the organism that regulates embryogenesis and development, maintains homeostasis of the immune system and removes potentially hazardous cells. A dysregulation of apoptosis signaling may thus disturb the balance of cell survival and cell death, leading to the development of several diseases including cancer. In order to determine whether osteosarcomas display an increased frequency of genetic alterations that affect apoptosis signaling, we analyzed the death domains of the death receptor genes CD95/Fas/ApoI, TNFRI, DR3/Apo3/WSL-l/LARD/TRAMP, DR5/TRAIL-R2/TRlCK2/KlLLER, DR6 and the complete coding sequences of the death receptor gene DR4/TRAIL-RI and the genes of the adaptors TRADD and FADD/MORT-1. The investigation included IS osteosarcoma tumor samples, 3 osteosarcoma cell lines (SAOS-2, HOS and MG63) and peripheral blood from 20 donors as controls. We were able to identify 4 different sequence variations within the DR4 gene located on exons 3, 4, 5 and 10 (death-domain). No alterations have been detected in the other genes or exons investigated. Except the sequence variant affecting exon 4, the alterations were homozygous in 15% of the tumor samples and cell lines, whereas the same alterations found in the control group were heterozygous or even not detectable. Three out of 4 alterations are located in the receptor's extracellular cysteine rich domain, which contains the ligand binding area and I on exon 10 coding for the death-domain. They may thus exert influence on ligand-receptor interactions and subsequent apoptosis induction. Our findings suggest that homozygous genetic alterations within the DR4 gene may be implicated in the formation of osteosarcoma. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 55 条
[1]
Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis [J].
Atkins, GJ ;
Bouralexis, S ;
Evdokiou, A ;
Hay, S ;
Labrinidis, A ;
Zannettino, ACW ;
Haynes, DR ;
Findlay, DM .
BONE, 2002, 31 (04) :448-456
[2]
How death shapes life during development [J].
Baehrecke, EH .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (10) :779-787
[3]
STRUCTURE OF THE HUMAN APO-1 GENE [J].
BEHRMANN, I ;
WALCZAK, H ;
KRAMMER, PH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3057-3062
[4]
Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia [J].
Beltinger, C ;
Böhler, T ;
Karawajew, L ;
Ludwig, WD ;
Schrappe, M ;
Debatin, KM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :722-728
[5]
Beltinger C, 1998, BLOOD, V91, P3943
[6]
The molecular architecture of the TNF superfamily [J].
Bodmer, JL ;
Schneider, P ;
Tschopp, J .
TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (01) :19-26
[7]
Initiator caspases in apoptosis signaling pathways [J].
Chen, M ;
Wang, J .
APOPTOSIS, 2002, 7 (04) :313-319
[8]
FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[9]
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 [J].
Chinnaiyan, AM ;
ORourke, K ;
Yu, GL ;
Lyons, RH ;
Garg, M ;
Duan, DR ;
Xing, L ;
Gentz, R ;
Ni, J ;
Dixit, VM .
SCIENCE, 1996, 274 (5289) :990-992
[10]
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170